Home | Welcome to Contract Pharma   
Last Updated Friday, August 1 2014
Print

Search Results for 'biotech'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published February 27, 2013
Adds single-use sensor technology with Aber partnership Read More »
Published November 29, 2012
To develop therapeutics that silence disease-causing genes Read More »
Published June 6, 2011
Evotec AG has entered into a medicinal chemistry collaboration with Active Biotech AB, following the successful conclusion of a High Throughput Screening campaign to identify small molecule modulators of Active Biotech’s priority biological target involved in immune disorders and cancer. Read More »
Published May 12, 2011
Oncolytics Biotech has entered into a commercial supply agreement with SAFC, a division of Sigma-Aldrich Corp., for the commercial manufacture of Oncolytics’ reovirus, Reolysin. Read More »
Published July 29, 2010
Aptuit, Inc. and Siena Biotech entered into a strategic partnership under which Siena Biotech will take a minority stake in Aptuit’s operations in Verona, Italy and Aptuit will serve as Siena’s provider of choice for its development pipeline. Read More »
Published April 29, 2010
Goodwin Biotechnology Inc., a full service contract biomanufacturing company, and Hyprocell LLC, a provider of clinical cell line development services, have entered into a collaboration agreement to create a business model enabling customers to access the Read More »
Published February 8, 2010
Teva Pharmaceutical Industries, Ltd. and Active Biotech have amended their marketing and distribution agreement for oral laquinimod, an investigational drug for relapsing-remitting multiple sclerosis (RRMS). Read More »
Published September 29, 2009
Laureate Pharma has entered into a development and manufacturing agreement with ZZ Biotech, LLC, under which Laureate will produce Activated Protein C variant under cGMP conditions. Read More »
Published September 12, 2008
MedImmune, the global biologics unit of AstraZeneca, and SBI Biotech Co., Ltd, have entered into a licensing and collaboration agreement to develop and commercialize SBI Biotech's anti-ILT7 protein for the potential treatment of systemic lupus erythe… Read More »
Published April 17, 2007
GE Healthcare, a unit of General Electric Co., has acquired Wave Biotech LLC, a supplier of disposable manufacturing technologies for the biopharmaceutical industry. The acquisition of Wave Biotech LLC, including its subsidiary Wave Europe Pvt. Ltd.,… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On